Novel treatment strategies for patients with relapsed classical Hodgkin lymphoma

Author:

Jona Adam,Younes Anas

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference66 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Defining a population of Hodgkin lymphoma patients for novel therapeutics: an international effort [abstract];Horning;Ann Oncol,2008

3. Novel small-molecule therapy of Hodgkin lymphoma;Buglio;Expert Rev Anticancer Ther,2007

4. The biology of Hodgkin's lymphoma;Kuppers;Nat Rev Cancer,2009

5. CD30/CD30 ligand and CD40/ CD40 ligand in malignant lymphoid disorders;Younes;Int J Biol Markers,1999

Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Advances in targeting histone deacetylase for treatment of solid tumors;Journal of Hematology & Oncology;2024-05-31

2. Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors;Cell Communication and Signaling;2024-02-08

3. CD30 in Cutaneous Pathology;The American Journal of Dermatopathology;2023-09

4. Advances in Hodgkin’s lymphoma pharmacotherapy: a focus on histone deacetylase inhibitors;Expert Opinion on Pharmacotherapy;2023-06-02

5. ABC-transporters and drug efflux in hematologic cancers;Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3